Investors should review the proxy materials and vote on the proposals, particularly the plan amendments, as they could impact future share dilution.
Price Chart
Executive Summary
Alto Neuroscience, Inc. (ANRO) is holding its 2026 Annual Meeting, where shareholders are being asked to vote on four proposals: electing two Class II directors, ratifying the selection of Deloitte & Touche LLP as the independent auditor, and approving amendments to the 2024 Equity Incentive Plan and the 2024 Employee Stock Purchase Plan to treat pre-funded warrants as common stock for share reserve calculations.
Key Facts
- Annual Meeting scheduled for May 12, 2026.
- Proposals include the election of two new directors: Raymond Sanchez, M.D. and Gwill York.
- Ratification of Deloitte & Touche LLP as the independent auditor for 2026.
- Amendments to the 2024 Equity Incentive Plan and the 2024 Employee Stock Purchase Plan to include pre-funded warrants in the 'evergreen' share reserve calculation.
Financial Impact
The amendments could increase the number of shares available for future grants, potentially leading to dilution.
Risk Factors
- Increased share dilution from the 'evergreen' feature of the amended plans.
- Potential governance concerns if the new directors are not independent or lack relevant experience.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-035191 |
| Document: 0001104659-26-035191-index-headers.html | 0001104659-26-035191 |
| Document: 0001104659-26-035191-index.html | 0001104659-26-035191 |
| Document: 0001104659-26-035191.txt | 0001104659-26-035191 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 10w ago | Institutional Cluster | $32.30 $34.25 | ▲ +6.04% | ▲ +8.00% | $23.19 (−28.20%) |
Jul 14, 2026 15w ago | 8-K | $27.80 $25.90 | ▲ +6.83% | ▲ +5.54% | $23.19 (+16.58%) |
Jul 14, 2026 15w ago | 424B5 | $27.80 $25.90 | ▲ +6.83% | ▲ +5.54% | $23.19 (+16.58%) |
Jul 13, 2026 15w ago | 8-K | $28.03 $27.54 | ▼ −1.75% | ▼ −0.96% | $23.19 (−17.27%) |
Jun 11, 2026 19w ago | Institutional Cluster | $21.47 $22.74 | ▲ +5.92% | ▲ +5.24% | $23.19 (+8.01%) |
May 29, 2026 21w ago | 3 | $19.80 $18.26 | ▼ −7.78% | ▼ −5.03% | $23.19 (+17.12%) |
May 28, 2026 21w ago | 8-K | $20.22 $18.85 | ▼ −6.78% | ▼ −6.73% | $23.19 (+14.69%) |
May 13, 2026 23w ago | 8-K | $22.85 $20.45 | ▼ −10.50% | ▼ −9.35% | $23.19 (+1.49%) |
Apr 21, 2026 27w ago | EFFECT | $25.59 $24.47 | ▼ −4.38% | ▼ −5.46% | $23.19 (−9.38%) |
Apr 10, 2026 28w ago | S-3 | $25.75 $27.33 | ▲ +6.14% | ▲ +2.84% | $23.19 (−9.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers